Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other financing activities (2020 - 2026)

Bioventus filings provide 6 years of Other financing activities readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Other financing activities rose 778.35% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $697000.0, a 191.95% increase, with the full-year FY2025 number at $697000.0, up 191.95% from a year prior.
  • Other financing activities hit $1.3 million in Q4 2025 for Bioventus, up from -$207000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $4.0 million in Q4 2023 to a low of -$376000.0 in Q4 2021.
  • Median Other financing activities over the past 5 years was -$83000.0 (2023), compared with a mean of $159050.0.
  • The widest YoY moves for Other financing activities: up 36418.18% in 2023, down 983.33% in 2023.
  • Bioventus' Other financing activities stood at -$376000.0 in 2021, then soared by 97.07% to -$11000.0 in 2022, then soared by 36418.18% to $4.0 million in 2023, then plummeted by 104.86% to -$194000.0 in 2024, then soared by 778.35% to $1.3 million in 2025.
  • The last three reported values for Other financing activities were $1.3 million (Q4 2025), -$207000.0 (Q3 2025), and -$209000.0 (Q2 2025) per Business Quant data.